78.10
price down icon0.15%   -0.12
after-market アフターアワーズ: 77.85 -0.25 -0.32%
loading
前日終値:
$78.22
開ける:
$77.49
24時間の取引高:
3.37M
Relative Volume:
0.73
時価総額:
$45.81B
収益:
$5.54B
当期純損益:
$4.18B
株価収益率:
11.16
EPS:
7
ネットキャッシュフロー:
$623.10M
1週間 パフォーマンス:
+4.15%
1か月 パフォーマンス:
+3.24%
6か月 パフォーマンス:
+10.73%
1年 パフォーマンス:
-10.12%
1日の値動き範囲:
Value
$76.25
$78.14
1週間の範囲:
Value
$75.28
$78.75
52週間の値動き範囲:
Value
$58.93
$95.25

Edwards Lifesciences Corp Stock (EW) Company Profile

Name
名前
Edwards Lifesciences Corp
Name
セクター
Healthcare (1166)
Name
電話
(949) 250-2500
Name
住所
ONE EDWARDS WAY, IRVINE, CA
Name
職員
15,800
Name
Twitter
@edwardslifesci
Name
次回の収益日
2025-02-11
Name
最新のSEC提出書
Name
EW's Discussions on Twitter

EW を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
EW
Edwards Lifesciences Corp
78.10 44.71B 5.54B 4.18B 623.10M 7.00
Medical Devices icon
ABT
Abbott Laboratories
133.57 231.29B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
104.17 157.07B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
380.86 146.67B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
83.74 104.07B 33.54B 4.66B 5.19B 3.62

Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-24 アップグレード Piper Sandler Neutral → Overweight
2025-01-30 アップグレード Stifel Hold → Buy
2025-01-16 ダウングレード Wolfe Research Peer Perform → Underperform
2024-12-16 アップグレード BofA Securities Neutral → Buy
2024-10-11 再開されました Morgan Stanley Equal-Weight
2024-09-18 ダウングレード Jefferies Buy → Hold
2024-07-31 アップグレード Daiwa Securities Neutral → Outperform
2024-07-29 アップグレード Wolfe Research Underperform → Peer Perform
2024-07-25 ダウングレード BofA Securities Buy → Neutral
2024-07-25 ダウングレード JP Morgan Overweight → Neutral
2024-07-25 ダウングレード Robert W. Baird Outperform → Neutral
2024-07-25 ダウングレード TD Cowen Buy → Hold
2024-07-25 ダウングレード Truist Buy → Hold
2024-05-30 開始されました Goldman Buy
2024-05-22 アップグレード Citigroup Neutral → Buy
2024-05-14 アップグレード Deutsche Bank Hold → Buy
2024-03-07 アップグレード BofA Securities Neutral → Buy
2024-02-02 アップグレード Wells Fargo Equal Weight → Overweight
2024-01-04 ダウングレード Evercore ISI Outperform → In-line
2023-12-11 ダウングレード Citigroup Buy → Neutral
2023-11-28 ダウングレード Wolfe Research Peer Perform → Underperform
2023-09-26 アップグレード Oppenheimer Perform → Outperform
2023-07-19 開始されました Robert W. Baird Outperform
2023-05-30 再開されました Morgan Stanley Overweight
2023-03-29 開始されました UBS Neutral
2023-03-08 ダウングレード Wells Fargo Overweight → Equal Weight
2023-02-06 ダウングレード Raymond James Outperform → Mkt Perform
2023-01-31 ダウングレード Bernstein Outperform → Underperform
2023-01-30 ダウングレード Piper Sandler Overweight → Neutral
2022-12-06 ダウングレード Stifel Buy → Hold
2022-10-28 ダウングレード Oppenheimer Outperform → Perform
2022-10-26 開始されました Mizuho Buy
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Buy
2022-07-29 ダウングレード Canaccord Genuity Buy → Hold
2022-04-13 開始されました Truist Buy
2022-04-06 開始されました Wolfe Research Outperform
2022-03-16 アップグレード Bernstein Mkt Perform → Outperform
2022-03-02 再開されました BofA Securities Neutral
2022-02-02 アップグレード UBS Neutral → Buy
2022-01-27 繰り返されました Citigroup Buy
2022-01-27 繰り返されました Evercore ISI Outperform
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました Stifel Buy
2022-01-27 繰り返されました UBS Neutral
2021-12-17 アップグレード JP Morgan Neutral → Overweight
2021-12-15 アップグレード Citigroup Neutral → Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-12-06 アップグレード Wells Fargo Equal Weight → Overweight
2021-07-30 繰り返されました Canaccord Genuity Buy
2021-07-30 繰り返されました Deutsche Bank Hold
2021-07-30 繰り返されました Jefferies Buy
2021-07-30 繰り返されました Morgan Stanley Overweight
2021-07-30 繰り返されました Oppenheimer Outperform
2021-07-30 繰り返されました Stifel Buy
2021-07-30 繰り返されました UBS Neutral
2021-07-30 繰り返されました Wells Fargo Equal Weight
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-04-05 アップグレード Evercore ISI In-line → Outperform
2020-12-16 ダウングレード Citigroup Buy → Neutral
2020-12-11 繰り返されました Canaccord Genuity Buy
2020-09-11 開始されました Wolfe Research Underperform
2020-04-28 ダウングレード Wells Fargo Overweight → Equal Weight
2020-04-17 アップグレード SVB Leerink Mkt Perform → Outperform
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-10 開始されました Oppenheimer Outperform
2020-01-02 ダウングレード Evercore ISI Outperform → In-line
2019-10-24 繰り返されました Canaccord Genuity Buy
2019-09-23 開始されました Piper Jaffray Overweight
2019-07-24 繰り返されました BofA/Merrill Buy
2019-03-18 繰り返されました Canaccord Genuity Buy
2019-01-18 アップグレード BofA/Merrill Neutral → Buy
2019-01-03 開始されました Deutsche Bank Hold
2018-11-28 開始されました UBS Neutral
2018-10-16 開始されました Barclays Underweight
2018-10-02 ダウングレード BofA/Merrill Buy → Neutral
2018-10-02 ダウングレード Guggenheim Buy → Neutral
すべてを表示

Edwards Lifesciences Corp (EW) 最新ニュース

pulisher
Jun 02, 2025

DBS Bank Adjusts Price Target on Edwards Lifesciences to $78 From $72, Maintains Hold Rating - marketscreener.com

Jun 02, 2025
pulisher
May 30, 2025

Leerink Partners Adjusts PT on Edwards Lifesciences to $83 From $77, Maintains Market Perform Rating - marketscreener.com

May 30, 2025
pulisher
May 28, 2025

Health Care Slips as Sector Continues to Lag Market -- Health Care Roundup - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Edwards Lifesciences stock rises following competitor’s exit - Investing.com

May 28, 2025
pulisher
May 24, 2025

Edwards Lifesciences’ SWOT analysis: stock poised for growth amid market expansion - Investing.com

May 24, 2025
pulisher
May 23, 2025

Edwards' data shows benefits of early intervention in aortic stenosis - BioWorld MedTech

May 23, 2025
pulisher
May 23, 2025

Edwards’ study demonstrates value in early aortic stenosis intervention - Yahoo Finance

May 23, 2025
pulisher
May 23, 2025

Edwards' New Late-Breaking Data on Severe AS Expected to Boost Stock - Yahoo Finance

May 23, 2025
pulisher
May 22, 2025

Assessing Edwards Lifesciences: Insights From 6 Financial Analysts - Benzinga

May 22, 2025
pulisher
May 22, 2025

Edwards Lifesciences (EW) Receives Price Target Increase from Ci - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Edwards Lifesciences (EW) Receives Price Target Increase from Citigroup | EW Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Edwards highlights cost savings, improved outcomes with prompt intervention for aortic stenosis - MassDevice

May 22, 2025
pulisher
May 22, 2025

Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Citigroup Adjusts Price Target on Edwards Lifesciences to $95 From $84, Maintains Buy Rating - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Citi Raises Price Target for Edwards Lifesciences (EW) to $95 | - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Analyst Elevates Edwards Lifesciences (EW) as Top Pick | EW Stoc - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Citi Raises Price Target for Edwards Lifesciences (EW) to $95 | EW Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Analyst Elevates Edwards Lifesciences (EW) as Top Pick | EW Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Citi adds Edwards Lifesciences stock as Top Pick, drops Insulet - Investing.com

May 22, 2025
pulisher
May 21, 2025

Edwards Lifesciences Holds 2025 EPS Outlook Despite Tariff Headwind - insights.citeline.com

May 21, 2025
pulisher
May 20, 2025

Jim Cramer Notes Edwards Lifesciences (EW) is in a “Good Zone” - Insider Monkey

May 20, 2025
pulisher
May 18, 2025

Edwards Gets FDA Approval for its Next-Generation TAVR Device - Medical Product Outsourcing

May 18, 2025
pulisher
May 16, 2025

Should Edwards Lifesciences Stock Remain in Your Portfolio Now? - Yahoo Finance

May 16, 2025
pulisher
May 15, 2025

Movers & Shakers: Grant Thornton, United Drug, Edwards Lifesciences, Fine Grain, Viatel, Kepak, EU Commission - Business Post

May 15, 2025
pulisher
May 14, 2025

Edwards Lifesciences Completes Sale of Critical Care - Quantisnow

May 14, 2025
pulisher
May 14, 2025

Do Wall Street Analysts Like Edwards Lifesciences Stock? - Nasdaq

May 14, 2025
pulisher
May 13, 2025

Edwards Lifesciences (EW) Sees Price Target Increase Amid Regula - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Edwards Lifesciences at BofA Conference: Strong Growth Amid Challenges By Investing.com - Investing.com Canada

May 13, 2025
pulisher
May 13, 2025

Edwards Lifesciences (EW) Sees Price Target Increase by Piper Sa - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Edwards Lifesciences at BofA Conference: Strong Growth Amid Challenges - Investing.com

May 13, 2025
pulisher
May 13, 2025

Piper Sandler Adjusts Price Target on Edwards Lifesciences to $83 From $80, Maintains Overweight Rating - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Piper Sandler raises Edwards Lifesciences target to $83 - Investing.com

May 13, 2025
pulisher
May 12, 2025

FDA Clears New Indication for Edwards’ Sapien 3 - Orange County Business Journal

May 12, 2025
pulisher
May 09, 2025

Why Edwards Lifesciences (EW) Is Among the Best Medical Device Stocks to Buy Now - Insider Monkey

May 09, 2025
pulisher
May 08, 2025

Edwards Lifesciences Corporation (EW) Announces Amendments to Employee Stock Purchase Plans - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Decoding Edwards Lifesciences Corp (EW): A Strategic SWOT Insigh - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Edwards Lifesciences First Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance

May 08, 2025
pulisher
May 06, 2025

Edwards Lifesciences CEO and CFO Set for Exclusive Fireside Chat at Major BofA Healthcare Conference - Stock Titan

May 06, 2025
pulisher
May 02, 2025

Edwards Lifesciences (NYSE:EW) Receives FDA Approval For Groundbreaking TAVR Therapy For Asymptomatic Patients - Yahoo Finance

May 02, 2025
pulisher
May 01, 2025

Edwards Lifesciences Gets FDA Approval for TAVR in Asymptomatic Aortic Stenosis - marketscreener.com

May 01, 2025
pulisher
May 01, 2025

Edwards wins FDA nod for TAVR in aortic stenosis without symptoms - MassDevice

May 01, 2025
pulisher
May 01, 2025

Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis - BioSpace

May 01, 2025
pulisher
May 01, 2025

FDA approves Edwards Lifesciences’ TAVR therapy By Investing.com - Investing.com India

May 01, 2025
pulisher
May 01, 2025

FDA approves Edwards Lifesciences’ TAVR therapy - Investing.com

May 01, 2025
pulisher
Apr 30, 2025

Edwards Lifesciences Corporation (EW): Jim Cramer Says It’s a Hold — But Is Boston Scientific Now His Favorite? - Insider Monkey

Apr 30, 2025
pulisher
Apr 28, 2025

Commit To Purchase Edwards Lifesciences At $60, Earn 6.8% Using Options - Nasdaq

Apr 28, 2025
pulisher
Apr 26, 2025

Edwards Lifesciences Corporation (NYSE:EW) Q1 2025 Earnings Call Transcript - Insider Monkey

Apr 26, 2025
pulisher
Apr 25, 2025

Edwards Lifesciences Reports Robust Q1 2025 Growth - TipRanks

Apr 25, 2025
pulisher
Apr 25, 2025

Edwards Lifesciences (EW) Price Target Raised by Canaccord Analy - GuruFocus

Apr 25, 2025

Edwards Lifesciences Corp (EW) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$85.51
price down icon 0.34%
$70.15
price down icon 0.55%
medical_devices SNN
$29.15
price up icon 0.66%
medical_devices STE
$242.08
price down icon 1.28%
$325.00
price down icon 0.01%
大文字化:     |  ボリューム (24 時間):